Cara Therapeutics, Inc.
General ticker "CARA" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $194.2M (TTM average)
Cara Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -23.9%.
Estimated limits based on current volatility of 3.9%: low 15.14$, high 16.35$
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [5.94$, 17.63$]
- 2025-12-31 to 2026-12-31 estimated range: [5.88$, 16.85$]
Financial Metrics affecting the CARA estimates:
- Negative: Non-GAAP EPS, $ of -20.04 <= 0.04
- Negative: Operating cash flow per share per price, % of -26.18 <= 1.79
- Negative: negative Net income
- Negative: negative Operating income
- Negative: Industry operating cash flow per share per price (median), % of -8.00 <= 2.82
- Negative: Shareholder equity ratio, % of -10.48 <= 22.52
- Positive: Interest expense per share, $ of 0.19 <= 0.67
- Negative: Industry earnings per price (median), % of -14.90 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term CARA quotes
Long-term CARA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $41.87MM | $20.97MM | $7.14MM |
| Operating Expenses | $129.40MM | $142.46MM | $65.52MM |
| Operating Income | $-87.53MM | $-121.50MM | $-58.38MM |
| Non-Operating Income | $2.06MM | $2.98MM | $-12.88MM |
| Interest Expense | $0.00MM | $0.60MM | $8.47MM |
| R&D Expense | $91.88MM | $108.51MM | $32.80MM |
| Income(Loss) | $-85.47MM | $-118.51MM | $-71.27MM |
| Taxes | $0.00MM | $0.00MM | $-0.40MM |
| Profit(Loss)* | $-83.41MM | $-118.51MM | $-70.87MM |
| Stockholders Equity | $158.78MM | $57.09MM | $-4.59MM |
| Inventory | $2.38MM | $2.82MM | $0.90MM |
| Assets | $182.24MM | $125.84MM | $43.83MM |
| Operating Cash Flow | $-78.73MM | $-92.08MM | $-60.92MM |
| Capital expenditure | $0.04MM | $2.38MM | $1.05MM |
| Investing Cash Flow | $128.71MM | $43.46MM | $48.74MM |
| Financing Cash Flow | $0.31MM | $38.15MM | $-3.60MM |
| Earnings Per Share** | $-1.55 | $-2.19 | $-1.55 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.